These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa]. Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. Carr DF; Bourgeois S; Chaponda M; Takeshita LY; Morris AP; Castro EM; Alfirevic A; Jones AR; Rigden DJ; Haldenby S; Khoo S; Lalloo DG; Heyderman RS; Dandara C; Kampira E; van Oosterhout JJ; Ssali F; Munderi P; Novelli G; Borgiani P; Nelson MR; Holden A; Deloukas P; Pirmohamed M J Antimicrob Chemother; 2017 Apr; 72(4):1152-1162. PubMed ID: 28062682 [TBL] [Abstract][Full Text] [Related]
25. Nevirapine-induced Stevens-Johnson syndrome in a mother and son. Liechty CA; Solberg P; Mwima G; Were W; Weidle PJ; Mermin J AIDS; 2005 Jun; 19(9):993-4. PubMed ID: 15905686 [No Abstract] [Full Text] [Related]
26. Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. Ciccacci C; Di Fusco D; Marazzi MC; Zimba I; Erba F; Novelli G; Palombi L; Borgiani P; Liotta G Eur J Clin Pharmacol; 2013 Nov; 69(11):1909-16. PubMed ID: 23774940 [TBL] [Abstract][Full Text] [Related]
27. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study. Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749 [TBL] [Abstract][Full Text] [Related]
28. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983 [TBL] [Abstract][Full Text] [Related]
30. [Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment]. Palacios Muñoz R; Santos González J; Bosch García R; Márquez Solero M Rev Clin Esp; 2000 Nov; 200(11):635-6. PubMed ID: 11196597 [No Abstract] [Full Text] [Related]
31. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Pollard RB; Robinson P; Dransfield K Clin Ther; 1998; 20(6):1071-92. PubMed ID: 9916603 [TBL] [Abstract][Full Text] [Related]
32. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Rotunda A; Hirsch RJ; Scheinfeld N; Weinberg JM Acta Derm Venereol; 2003; 83(1):1-9. PubMed ID: 12636014 [TBL] [Abstract][Full Text] [Related]
33. Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population. Carr DF; Chaponda M; Jorgensen AL; Castro EC; van Oosterhout JJ; Khoo SH; Lalloo DG; Heyderman RS; Alfirevic A; Pirmohamed M Clin Infect Dis; 2013 May; 56(9):1330-9. PubMed ID: 23362284 [TBL] [Abstract][Full Text] [Related]
34. Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis. Hirapara HN; Patel TK; Barvaliya MJ; Tripathi C Niger J Clin Pract; 2017 Aug; 20(8):978-983. PubMed ID: 28891542 [TBL] [Abstract][Full Text] [Related]
35. Stevens-Johnson syndrome and HIV in children in Swaziland. Dziuban EJ; Hughey AB; Stewart DA; Blank DA; Kochelani D; Draper HR; Schutze GE Pediatr Infect Dis J; 2013 Dec; 32(12):1354-8. PubMed ID: 23743542 [TBL] [Abstract][Full Text] [Related]
36. [Stevens-Johnson syndrome due to nevirapine]. García Fernández D; García-Patos Briones V; Mollet Sánchez J; Castells Rodellas A Rev Clin Esp; 2000 Mar; 200(3):179-80. PubMed ID: 10804771 [No Abstract] [Full Text] [Related]
37. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132 [TBL] [Abstract][Full Text] [Related]
38. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin. Phan TG; Wong RC; Crotty K; Adelstein S Australas J Dermatol; 1999 Aug; 40(3):153-7. PubMed ID: 10439528 [TBL] [Abstract][Full Text] [Related]
39. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197 [TBL] [Abstract][Full Text] [Related]